GeoVax Labs (GOVX) Earnings Date & Reports

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GOVX is expected to report earnings to fall 74.03% to -22 cents per share on March 21

Q4'23

Est.

$-0.22

Q4'24

Missed

by $0.68

Q3'23

Missed

by $4.60

Q2'23

Missed

by $0.05

Q1'23

Missed

by $2.05

The last earnings report on March 27 showed earnings per share of -86 cents, missing the estimate of -18 cents. With 621.30K shares outstanding, the current market capitalization sits at 11.32M.

View a ticker or compare two or three

Compare

GOVX